Lupin extends gain as UK MHRA completes inspection at Goa unit

The stock was up 3% to Rs 798, extending its Monday's 5% surge on the BSE

Lupin receives US FDA for electrolyte replenisher
SI Reporter Mumbai
Last Updated : Apr 03 2018 | 12:12 PM IST
Lupin was up 3% to Rs 798, extending its Monday’s 5% surge on the BSE, after the company announced the successful completion of the inspection by the UK MHRA at its Goa facility in March, 2018.

There were no critical or major observations in the inspection, Lupin said in a press release.

"We are committed to maintaining truly global quality standards at our manufacturing units. The successful inspection by UK MHRA is a meaningful development for our Goa plant,” said Nilesh Gupta, Managing Director, Lupin.

On Monday, April 2, Lupin announced the successful facility review carried out by Health Canada for its Pithampur Unit 2 (Indore) manufacturing facility. 

Following the review, Health Canada has maintained the compliant rating for Unit 2 at Pithampur (Indore) and has issued a revised 'Establishment License,’ it added.

At 12:07 pm; the stock was trading 1.5% higher at Rs 787 on the BSE, against 0.21% decline in the S&P BSE Sensex.  A combined 1.62 million shares changed hands on the counter on the BSE and NSE so far.

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Next Story